专利检索 ap:("Centaurus Biopharma Co., Ltd.") AND inv:"TANG, Jia" 第 1 页

1.

发明公开
2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS 审中-公开
标题翻译： 2,4-二氨基-6,7-二氢-5H-吡咯并[2,3-b]嘧啶衍生物ALS FAK / PYK2-HEMMER

公开(公告)号：EP2661437A1

公开(公告)日：2013-11-13

申请号：EP12732345.9

申请日：2012-01-07

申请人： Centaurus Biopharma Co., Ltd.

发明人： XIAO, Dengming , CHENG,Liang , LIU, Xijie , HU, Yuandong , XU, Xinhe , LIU, Zhihua , ZHANG, Lipeng , WU, Wei , WANG, Shulong , SHEN, Yu , LI, Gen , WANG, Yin , ZHAO, Sheng , LI, Chonglong , TANG, Jia , YU, Honghao

IPC分类号： C07D487/04 , A61K31/505 , A61P35/00 , A61P29/00 , A61P31/00 , A61P37/02

CPC分类号： C07D487/04 , A61K31/4523 , A61K31/519 , A61K31/5377 , A61K31/541 , C07D401/12 , C07D413/12 , C07D417/12 , C07D493/12

摘要： The invention relates to a novel class of 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as a FAK and/or Pyk2 inhibitor, to a process for their preparation, and to a composition thereof, as well as to use of the compounds for the inhibiting FAK and/or Pyk2 and method for the treatment of a FAK and/ or Pyk2 mediated disorder or disease.